The Innovation Implementation Gap
This white paper explores why useful RTSM functionality is often discussed, valued, and then left out when studies move from planning into execution. It argues that the problem is not a lack of innovation, but a tendency to evaluate functionality through the lens of launch rather than the longer realities of live study maintenance, operational burden, and change.
Built to Adapt - Supporting Dose Escalation and Expansion Studies
This white paper looks at why dose escalation and expansion studies require RTSM that can absorb movement, not simply support launch. It discusses how dose changes, cohort evolution, schedule variation, and patient movement quickly increase complexity, and explains why planning for likely change early leads to more controlled, efficient study execution.
Balancing Quality and Innovation for eClinical Technology
This white paper explores how a mature Quality Management System (QMS) and Quality by Design principles create a stable foundation for sustainable innovation in Randomization and Trial Supply Management (RTSM).